Buy 2CBCB-NBOMe Cas 1354634-09-5
Buy 2CBCB-NBOMe Cas 1354634-09-5
2CBCB-NBOMe, or NBOMe-TCB-2, is a serotonin receptor modulator and cyclized phenethylamine.[1][2] It is the NBOMe derivative of the psychedelic drug TCB-2 (2C-BCB).[1][2]
Interactions
Pharmacology
Pharmacodynamics
2CBCB-NBOMe acts as a potent and selective agonist of the serotonin 5-HT2A and 5-HT2C receptors, with an affinity (Ki) of 0.27 nM at the human serotonin 5-HT2A receptor, similar to that of other drugs such as TCB-2, 25I-NBOMe, and Bromo-DragonFLY.[1][2]
History
2CB2CB-NBOMe was first described in the scientific literature by the lab of David E. Nichols and colleagues in 2007.[1][2] It was part of an ongoing research program focused on mapping of the specific amino acid residues responsible for ligand binding to the serotonin 5-HT2A receptor.[1][2]
Society and culture
Legal status
Canada
2CBCB-NBOMe is not a controlled substance in Canada as of 2025.[3]
United Kingdom
This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[4]
United States
2CBCB-NBOMe is a controlled substance in Vermont as of January 2016.[5]
Reviews
There are no reviews yet.